Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2003

View Archived Issues

TROICA study evaluates tenecteplase for cardiac arrest

MIV-210 effective in vitro against resistant viruses

Four related series of MMP inhibitors and their use patented by Pfizer

Lilly researchers claim two novel series of tachykinin NK1 antagonists

Teijin scientists identify new piperidine-based CCR3 antagonists

Sumitomo patent covers new antidiabetic PPARalpha and/or PPARgamma agonists

New hypocholesterolemic polymers developed at Taisho

Shionogi researchers discover new NADPH oxidase inhibitors

Trial commences for ADVAX HIV/AIDS vaccine

Eculizumab granted U.S. and E.U. orphan drug designations for PNH

Preliminary phase III results for Vivitrex show reductions in heavy drinking

Allergan and Inspire sign copromotion agreement for Elestat

Encouraging outcomes for Rituxan phase II and III trials

Interim results from phase II studies of HuMax-CD4 for CTCL

GlaxoSmithKline to advance 480848 into phase III trials in 2004

INGN-225 to be studied for advanced breast cancer in phase I/II trial

Sugen identifies potential surrogate markers for SU-11248 activity

New phase II trials to evaluate KOS-862 for various cancers

Novactyl seeks licensing partner for PCL-016

Enrollment under way in second phase of BEYOND Betaferon trial

SARS vaccine induces T-cell and antibody responses in animal study

Antitumor activity of E-7070 in metastatic breast cancer

Novel strategy to block SARS virus replication

Fluoxetine safe and effective for adolescents with bulimia nervosa

Improved survival with RSR-13 plus WBRT in breast cancer patients with brain metastases

Antitumor efficacy of Bay-59-8862 in metastatic breast cancer

Novel inhibitor of Stat3 activation with activity against hematological malignancies

Improved antiemetic efficacy of aprepitant compared to standard regimen in both men and women

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...